相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Possible warfarin resistance due to interaction with ascorbic acid: Case report and literature review
Adil Sattar et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2013)
Drug-Drug Interactions Between Warfarin and Psychotropics: Updated Review of the Literature
Ashwini Nadkarni et al.
PHARMACOTHERAPY (2012)
Present Status of Anticoagulation Treatment in Japanese Patients With Atrial Fibrillation - A Report From the J-RHYTHM Registry
Hirotsugu Atarashi et al.
CIRCULATION JOURNAL (2011)
Interactive Modeling for Ongoing Utility of Pharmacogenetic Diagnostic Testing: Application for Warfarin Therapy
Mark W. Linder et al.
CLINICAL CHEMISTRY (2009)
Rapid Single-Nucleotide Polymorphism Detection of Cytochrome P450 (CYP2C9) and Vitamin K Epoxide Reductase (VKORC1) Genes for the Warfarin Dose Adjustment by the SMart-Amplification Process Version 2
Tohru Aomori et al.
CLINICAL CHEMISTRY (2009)
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
B. F. Gage et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Estimation of warfarin maintenance dose based on VKORCI (-1639 G>A) and CYP2C9 genotypes
Yusheng Zhu et al.
CLINICAL CHEMISTRY (2007)
Association of warfarin dose with genes involved in its action and metabolism
Mia Wadelius et al.
HUMAN GENETICS (2007)
VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients
Kyoko Obayashi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose
D Herman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity
HY Yuan et al.
HUMAN MOLECULAR GENETICS (2005)
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
G D'Andrea et al.
BLOOD (2005)
Identification of the gene for vitamin K epoxide reductase
T Li et al.
NATURE (2004)
The pharmacology and management of the vitamin K antagonists
J Ansell et al.
CHEST (2004)
Pharmacogenetics of oral anticoagulants
AK Daly et al.
PHARMACOGENETICS (2003)
Cytochrome P4502C9 polymorphisms: a comprehensive review of the in-vitro and human data
CR Lee et al.
PHARMACOGENETICS (2002)
Pharmacogenetics of warfarin elimination and its clinical implications
H Takahashi et al.
CLINICAL PHARMACOKINETICS (2001)
分享论文
